Ind-Swift Laboratories Ltd. Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ind-Swift Laboratories Ltd.'s estimated annual revenue is currently $119M per year.(i)
  • Ind-Swift Laboratories Ltd.'s estimated revenue per employee is $201,000

Employee Data

  • Ind-Swift Laboratories Ltd. has 592 Employees.(i)
  • Ind-Swift Laboratories Ltd. grew their employee count by -8% last year.

Ind-Swift Laboratories Ltd.'s People

NameTitleEmail/Phone
1
CEO Ind-Swift Labs LimitedReveal Email/Phone
2
SVP & Head- R&D + CRAMSReveal Email/Phone
3
Senior ManagerReveal Email/Phone
4
Deputy ManagerReveal Email/Phone
5
Assistant Manager EngineeringReveal Email/Phone
6
Manager- API MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Ind-Swift Laboratories Ltd.?

Established in 1995 Ind-Swift has fast evolved towards a business model that is focused on deep-rooted domestic presence and leveraged on high-value mature regulated markets along with considerable growth in emerging markets: Ind-Swift Laboratories Ltd. (Manufacturer of APIs) Ind-Swift Ltd. (Manufacturer of Finished Dosage Forms) Ind-Swift Laboratories Inc. (US Subsidiary) Ind Swift Menthol With manufacturing sites at 6 different locations across India and an independent State-of-the-Art R&D Centre, the Group has embarked upon a journey to establish itself as reliable partner in the Global Pharmaceutical Industry. In house capabilities for Development of APIs, Finished Dosage forms, Non-Infringing Process & World Class facilities for Contract Manufacturing are the inherent strengths.

keywords:N/A

N/A

Total Funding

592

Number of Employees

$119M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ind-Swift Laboratories Ltd. News

2022-04-19 - Ranolazine Market Size, Scope And Outlook | JSN chemicals ...

... Precise Chemipharma, Nuray Chemicals, Emmennar, SVK Laboratories Private Limited, Ind-Swift Laboratories Ltd, Wuhai Fulin Bio-Technology and Srini.

2022-03-22 - Healthcare shares fall

On the other hand, Suven Life Sciences Ltd (up 13.22%), Ind-Swift Laboratories Ltd (up 9.63%), and Thyrocare Technologies Ltd (up 6.24%) moved...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M592-3%N/A
#2
$199.8M5925%N/A
#3
$133.2M592-2%N/A
#4
$244.6M593N/AN/A
#5
$75M593N/AN/A